Brooklyn Investment Group Takes Position in CME Group Inc. (NASDAQ:CME)

Brooklyn Investment Group purchased a new position in CME Group Inc. (NASDAQ:CME) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 1,266 shares of the financial services provider’s stock, valued at approximately $279,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. FMR LLC increased its holdings in CME Group by 3.5% in the 3rd quarter. FMR LLC now owns 1,108,360 shares of the financial services provider’s stock valued at $244,560,000 after acquiring an additional 37,911 shares during the last quarter. D.A. Davidson & CO. increased its holdings in shares of CME Group by 0.4% in the third quarter. D.A. Davidson & CO. now owns 30,202 shares of the financial services provider’s stock worth $6,664,000 after purchasing an additional 120 shares during the last quarter. Bank of Montreal Can lifted its position in shares of CME Group by 41.8% in the third quarter. Bank of Montreal Can now owns 1,028,090 shares of the financial services provider’s stock worth $224,432,000 after buying an additional 303,169 shares in the last quarter. Truvestments Capital LLC bought a new position in CME Group during the third quarter valued at approximately $26,000. Finally, Independent Advisor Alliance grew its holdings in CME Group by 2.5% during the 3rd quarter. Independent Advisor Alliance now owns 7,135 shares of the financial services provider’s stock valued at $1,574,000 after buying an additional 175 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on CME shares. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $235.00 price objective on shares of CME Group in a report on Thursday, October 24th. Bank of America increased their price objective on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday, October 3rd. Redburn Atlantic downgraded shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price on the stock. in a report on Tuesday, October 8th. TD Cowen started coverage on CME Group in a research report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price target for the company. Finally, Citigroup upped their price objective on CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a research report on Thursday, October 24th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, CME Group currently has an average rating of “Hold” and a consensus price target of $224.47.

Insider Buying and Selling

In related news, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the transaction, the director now owns 25,067 shares in the company, valued at $5,587,935.64. The trade was a 1.57 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The trade was a 12.01 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,621 shares of company stock worth $3,441,063 in the last three months. 0.30% of the stock is owned by insiders.

CME Group Trading Up 2.2 %

Shares of NASDAQ CME opened at $234.39 on Wednesday. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $235.18. The firm has a market cap of $84.47 billion, a PE ratio of 24.65, a price-to-earnings-growth ratio of 5.28 and a beta of 0.55. The business has a fifty day simple moving average of $224.18 and a two-hundred day simple moving average of $211.37. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company’s revenue for the quarter was up 18.4% on a year-over-year basis. During the same quarter last year, the firm posted $2.25 EPS. Analysts expect that CME Group Inc. will post 10.22 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be given a $1.15 dividend. This represents a $4.60 annualized dividend and a dividend yield of 1.96%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s payout ratio is 48.37%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.